Anish Patel's most recent trade in Enliven Therapeutics Inc was a trade of 120,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 12 Feb 2026 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 20,000 | 20,000 | - | 0 | Common Stock | |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 27.98 per share. | 09 Jan 2026 | 48,057 | 215,254 | - | 28.0 | 1,344,837 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 28.50 per share. | 09 Jan 2026 | 243 | 215,011 | - | 28.5 | 6,926 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 20.76 per share. | 08 Dec 2025 | 4,958 | 265,016 | - | 20.8 | 102,939 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 21.78 per share. | 08 Dec 2025 | 1,705 | 263,311 | - | 21.8 | 37,134 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 07 Nov 2025 | 6,054 | 270,587 | - | 17.4 | 105,039 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 17.94 per share. | 07 Nov 2025 | 613 | 269,974 | - | 17.9 | 10,995 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 07 Oct 2025 | 6,667 | 276,641 | - | 20.1 | 133,993 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 20.24 per share. | 08 Sep 2025 | 6,667 | 283,308 | - | 20.2 | 134,957 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 18.20 per share. | 07 Aug 2025 | 6,262 | 290,380 | - | 18.2 | 113,949 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 18.93 per share. | 07 Aug 2025 | 405 | 289,975 | - | 18.9 | 7,667 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 19.75 per share. | 07 Jul 2025 | 6,362 | 296,947 | - | 19.7 | 125,639 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 20.70 per share. | 07 Jul 2025 | 305 | 296,642 | - | 20.7 | 6,312 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 20.33 per share. | 09 Jun 2025 | 6,607 | 303,369 | - | 20.3 | 134,304 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 21.17 per share. | 09 Jun 2025 | 60 | 303,309 | - | 21.2 | 1,270 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 18.30 per share. | 07 May 2025 | 6,173 | 310,470 | - | 18.3 | 112,947 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 19.40 per share. | 07 May 2025 | 390 | 310,080 | - | 19.4 | 7,565 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 19.88 per share. | 07 May 2025 | 104 | 309,976 | - | 19.9 | 2,067 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 07 Apr 2025 | 3,756 | 319,554 | - | 17.8 | 66,889 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 18.29 per share. | 07 Apr 2025 | 2,763 | 316,791 | - | 18.3 | 50,527 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 19.27 per share. | 07 Apr 2025 | 148 | 316,643 | - | 19.3 | 2,852 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 21.44 per share. | 07 Mar 2025 | 6,667 | 323,310 | - | 21.4 | 142,936 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 06 Feb 2025 | 171,000 | 171,000 | - | - | Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 06 Feb 2025 | 6,667 | 329,977 | - | 21.9 | 146,206 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.15 per share. | 07 Jan 2025 | 20,260 | 1,440 | - | 24.2 | 489,330 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 07 Jan 2025 | 10,700 | 10,700 | - | 1.1 | 11,984 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 07 Jan 2025 | 10,700 | 67 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 07 Jan 2025 | 9,000 | 44,342 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 07 Jan 2025 | 9,000 | 21,700 | - | 2.5 | 22,320 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.17 per share. | 07 Jan 2025 | 6,577 | 336,734 | - | 24.2 | 158,957 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 07 Jan 2025 | 2,000 | 827 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 07 Jan 2025 | 2,000 | 12,700 | - | 2.5 | 4,960 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.56 per share. | 07 Jan 2025 | 1,440 | 0 | - | 24.6 | 35,368 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.60 per share. | 07 Jan 2025 | 90 | 336,644 | - | 24.6 | 2,214 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 18 Oct 2024 | 716 | 343,311 | - | 30.0 | 21,483 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 12 Jul 2024 | 30,978 | 345,574 | - | 25.1 | 776,039 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 12 Jul 2024 | 17,475 | 376,552 | - | 25.1 | 438,095 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.01 per share. | 12 Jul 2024 | 1,547 | 344,027 | - | 25.0 | 38,692 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 06 Jun 2024 | 1,133 | 53,342 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 06 Jun 2024 | 1,133 | 0 | - | 20.1 | 22,722 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 06 Jun 2024 | 1,133 | 1,133 | - | 2.5 | 2,810 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 14 May 2024 | 1,107 | 1,107 | - | 2.5 | 2,745 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 14 May 2024 | 1,107 | 54,475 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 14 May 2024 | 1,107 | 0 | - | 25 | 27,675 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 09 May 2024 | 260 | 260 | - | 2.5 | 645 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 09 May 2024 | 260 | 0 | - | 25.1 | 6,515 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 09 May 2024 | 260 | 55,582 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 22.72 per share. | 06 May 2024 | 4,875 | 0 | - | 22.7 | 110,769 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 06 May 2024 | 4,875 | 55,842 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 06 May 2024 | 4,875 | 4,875 | - | 2.5 | 12,090 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 11 Apr 2024 | 17,500 | 0 | - | 25.0 | 438,099 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 11 Apr 2024 | 14,903 | 17,500 | - | 2.5 | 36,959 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 11 Apr 2024 | 14,903 | 60,717 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 08 Apr 2024 | 4,331 | 3,141 | - | 18.5 | 80,134 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 19.40 per share. | 08 Apr 2024 | 544 | 2,597 | - | 19.4 | 10,552 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 15.64 per share. | 06 Mar 2024 | 4,875 | 7,472 | - | 15.6 | 76,239 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | 13 Feb 2024 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 06 Feb 2024 | 4,875 | 12,347 | - | 15.1 | 73,658 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel, Pharm.D. | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 22 Jan 2024 | 4,875 | 17,222 | - | 15.1 | 73,783 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Dec 2023 | 11,000 | 22,097 | - | 15.0 | 165,053 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 28 Dec 2023 | 2,520 | 33,117 | - | 15.1 | 37,996 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Dec 2023 | 20 | 33,097 | - | 15 | 300 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 22 Dec 2023 | 983 | 35,739 | - | 15.0 | 14,776 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 22 Dec 2023 | 102 | 35,637 | - | 15.0 | 1,531 | Common Stock |
| LifeStance Health Grp Inc | Dr. Anisha Patel-Dunn, D.O. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 28 Jun 2023 | 2,602 | 277,055 | - | 9.2 | 24,042 | Common Stock |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | 04 Apr 2023 | 206,000 | 206,000 | - | - | Stock Option (right to buy) | ||
| LifeStance Health Grp Inc | Dr. Anisha Patel-Dunn, D.O. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.62 per share. | 04 Apr 2023 | 7,319 | 279,657 | - | 7.6 | 55,771 | Common Stock |
| LifeStance Health Grp Inc | Dr. Anisha Patel-Dunn, D.O. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 192,307 | 286,976 | - | 0 | Common Stock | |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 394,027 | 394,027 | - | - | Common Stock | |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | 23 Feb 2023 | 75,620 | 75,620 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 36,722 | 36,722 | - | - | Common Stock | |
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | 23 Feb 2023 | 10,767 | 10,767 | - | - | Employee Stock Option (right to buy) | ||
| Enliven Therapeutics Inc | Dr. Anish Patel | Chief Operating Officer | 23 Feb 2023 | 2,827 | 2,827 | - | - | Employee Stock Option (right to buy) | ||
| LifeStance Health Grp Inc | Dr. Anisha Patel-Dunn, D.O. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.34 per share. | 13 Jun 2022 | 3,463 | 94,669 | - | 5.3 | 18,492 | Common Stock |
| LifeStance Health Grp Inc | Dr. Anisha Patel-Dunn, D.O. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 76,446 | 98,132 | - | 0 | Common Stock |